DK0707853T3 - Muselrelakserende farmaceutiske præparater - Google Patents

Muselrelakserende farmaceutiske præparater

Info

Publication number
DK0707853T3
DK0707853T3 DK95115576.1T DK95115576T DK0707853T3 DK 0707853 T3 DK0707853 T3 DK 0707853T3 DK 95115576 T DK95115576 T DK 95115576T DK 0707853 T3 DK0707853 T3 DK 0707853T3
Authority
DK
Denmark
Prior art keywords
pharmaceuticals
tryptophan
serine
glycine
muscle relaxing
Prior art date
Application number
DK95115576.1T
Other languages
Danish (da)
English (en)
Inventor
Stefano Poli
Tiziano Crimella
Ambrogio Magni
Luigi Moro
Original Assignee
Poli Ind Chimica Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11369756&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0707853(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Poli Ind Chimica Spa filed Critical Poli Ind Chimica Spa
Application granted granted Critical
Publication of DK0707853T3 publication Critical patent/DK0707853T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK95115576.1T 1994-10-21 1995-10-02 Muselrelakserende farmaceutiske præparater DK0707853T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI942166A IT1271031B (it) 1994-10-21 1994-10-21 Composizioni farmaceutiche miorilassanti

Publications (1)

Publication Number Publication Date
DK0707853T3 true DK0707853T3 (da) 1998-03-02

Family

ID=11369756

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95115576.1T DK0707853T3 (da) 1994-10-21 1995-10-02 Muselrelakserende farmaceutiske præparater

Country Status (9)

Country Link
EP (1) EP0707853B1 (de)
AT (1) ATE156016T1 (de)
CA (1) CA2160938C (de)
DE (2) DE69500490T2 (de)
DK (1) DK0707853T3 (de)
ES (1) ES2088379T3 (de)
GR (2) GR960300039T1 (de)
HK (1) HK1001719A1 (de)
IT (1) IT1271031B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6911455B2 (en) 1999-12-22 2005-06-28 Smithkline Beecham Corporation Methods for preparing pharmaceutical formulations
CA2394794C (en) * 1999-12-22 2009-08-25 Glaxo Group Limited Methods for preparing pharmaceutical formulations
DE102005030423A1 (de) * 2005-06-30 2007-01-04 Inresa Arzneimittel Gmbh Neue Formulierung für Vecuroniumbromid
CN101325947A (zh) * 2005-12-08 2008-12-17 惠氏公司 脂质体组合物
EP2712611A1 (de) 2012-09-27 2014-04-02 B. Braun Melsungen AG Stabilisierte wässrige Zusammensetzungen von neuromuskulären Blockiermitteln
RU2594062C2 (ru) * 2013-07-23 2016-08-10 Закрытое акционерное общество "ЭкоФармПлюс" Способ получения фармацевтического состава рокурония бромида в форме стабильного лиофилизата и фармацевтический состав, полученный этим способом
CN107638391B (zh) * 2016-07-22 2020-10-16 海南合瑞制药股份有限公司 一种注射用苯磺顺阿曲库铵组合物
CN108676052B (zh) * 2018-08-16 2020-05-22 北京市新里程医药科技有限公司 一种罗库溴铵的制备方法及其药物组合物
CN111374942B (zh) * 2018-12-30 2022-09-13 鲁南制药集团股份有限公司 一种甾体类肌松药注射液及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU675930B2 (en) * 1992-02-18 1997-02-27 Pharmos Corp. Dry compositions for preparing submicron emulsions
GB9302455D0 (en) * 1993-02-08 1993-03-24 Lab Inpharm N V Process for preparing a pharmaceutical preparation having neuromuscular blocking activity

Also Published As

Publication number Publication date
EP0707853A1 (de) 1996-04-24
DE69500490T2 (de) 1997-12-04
DE69500490D1 (de) 1997-09-04
ITMI942166A1 (it) 1996-04-21
CA2160938C (en) 2008-07-15
ES2088379T1 (es) 1996-08-16
GR960300039T1 (en) 1996-08-31
ES2088379T3 (es) 1997-10-16
EP0707853B1 (de) 1997-07-30
DE707853T1 (de) 1996-12-12
CA2160938A1 (en) 1996-04-22
GR3024761T3 (en) 1997-12-31
ATE156016T1 (de) 1997-08-15
ITMI942166A0 (it) 1994-10-21
HK1001719A1 (en) 1998-07-03
IT1271031B (it) 1997-05-26

Similar Documents

Publication Publication Date Title
DE69614681D1 (de) Pharmazeutische und/oder diätische zusammensetzungen mit antioxydationswirkung, welche carnosin und verzweigte aminosäure enthalten
PT792287E (pt) Analogos peptidicos da proteina basica da mielina humana
IT1255258B (it) Composizioni farmaceutiche per l'applicazione per via nasale.
DE69604147D1 (de) Flüssige zuzammensetzung zur stabilisierung von aminosäure-herbiziden
HK1039271A1 (en) Method for prevention and/or cosmetic treatment ofskin stripe and use in dermatology.
BR9713404A (pt) ésteres de n-(aril/heteroarilacetil) aminoácidos, composições farmacêuticas compreendendo os mesmos, e métodos para a inibição da liberação de peptìdeo beta-amilóide e/ou de sua sìntese por uso de tais compostos.
TR199901132T2 (xx) N-(aril/heteoaril) amino asit t�revleri, bunlar� i�eren farmas�tik bile�imler ve b�yle bile�ikler kullan�larak �-amiloid peptidinin sal�nmas�n� ve/veya sentezini inhibe etmek i�in y�ntemler.
ATE513847T1 (de) Bioaktive peptide
ZA98214B (en) Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1.
RU95106674A (ru) Полиеновые соединения, фармацевтическая и косметическая композиция на их основе
DK0707853T3 (da) Muselrelakserende farmaceutiske præparater
ATE245999T1 (de) Aminosäurezusammensetzungen
EA200100354A1 (ru) Фармацевтическая композиция, содержащая энтакапон или нитекапон, а также поперечно-сшитое производное целлюлозы
ATE280777T1 (de) Bradykinin-antagonist peptide mit n- substituierten glycinen
ES2177024T3 (es) Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer.
ES2121940T3 (es) Composiciones antitumorales y procedimientos de tratamiento.
ATE201693T1 (de) Hämoregulierende peptide
YU20050685A (sh) Poboljšanje podnošljivosti farmaceutski delotvornih beta- amino kiselina
BG103632A (en) Pharmaceutical compositions containing ibuprophene and domperidon for migraine treatment
RU94041028A (ru) Применение производных мелатонина для лечения десинхронизационных нарушений, фармацевтическая композиция
KR970073601A (ko) 생리 활성 펩티드 함유 경비 투여용 조성물
ATE219763T1 (de) Amid enthaltende kosmetische zusammensetzungen und neue amide
HUP0002236A2 (hu) Oldhatóvá tett szertralinkészítmények és eljárás az előállításukra
FI942938A0 (fi) Soijaproteiini tai -hydrolysaatit farmaseuttisissa koostumuksissa bioaktiivisten peptidien suojana entsymaattista inaktivoitumista vastaan
SE9901773D0 (sv) Förebyggande av karies i tänderna